Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Follow the Money: AI Drug Treatments, Stocks, Quantum Metabolic Polarizers, More

    Diagnostics World | Leveraging AI for drug treatments, stock investments, revolutionizing metabolic MRIs with polarizers, and more.

    Jun 27, 2023
  • Wearable Scores Better Than Gold-Standard Test In Detecting Sleep Apnea

    Diagnostics WorldAs anyone who has ever needed a sleep study is aware, it’s neither convenient nor fun and can easily cost several thousand dollars. Polysomnography (PSG), the gold standard for diagnosing obstructive sleep apnea, typically requires an overnight stay at a sleep disorders unit within a hospital or at a sleep center with a long wait to even get scheduled.

    Jun 22, 2023
  • Platform and Projects: Genomics England’s New Efforts

    Diagnostics World | At the Bio-IT World Conference & Expo last month, members of the Genomics England team shared about the organization’s history, vision, and what it’s working on now.

    Jun 21, 2023
  • Animal Alternatives: Why Tumoroids, 3D Bioprinting, and Other Technologies Could Reshape the Search for Improved Cancer Treatments

    Diagnostics World | As the field of bioengineering progresses, emerging technologies are aiming to mimic tumors more effectively and pave the way toward improved cancer treatments. These technologies are becoming even more relevant since the Food and Drug Administration Modernization Act 2.0, which enables the use of animal testing alternatives for the study of drug safety and effectiveness.

    Jun 20, 2023
  • «
  • 51
  • 52 (current)
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy